A guide for the diagnosis of rare and undiagnosed disease: beyond the exome

Руководство по диагностике редких и недиагностированных заболеваний: за пределами экзома
Joshua W. Knowles, Euan Angus Ashley, Shruti Marwaha
2022-02-27

long-read sequencingmulti-omics profilingphenotype matchingundiagnosed rare diseaseswhole-genome sequencing
Rare diseases affect 30 million people in the USA and more than 300-400 million worldwide, often causing chronic illness, disability, and premature death. Traditional diagnostic techniques rely heavily on heuristic approaches, coupling clinical experience from prior rare disease presentations with the medical literature. A large number of rare disease patients remain undiagnosed for years and many even die without an accurate diagnosis. In recent years, gene panels, microarrays, and exome sequencing have helped to identify the molecular cause of such rare and undiagnosed diseases. These technologies have allowed diagnoses for a sizable proportion (25-35%) of undiagnosed patients, often with actionable findings. However, a large proportion of these patients remain undiagnosed. In this review, we focus on technologies that can be adopted if exome sequencing is unrevealing. We discuss the benefits of sequencing the whole genome and the additional benefit that may be offered by long-read technology, pan-genome reference, transcriptomics, metabolomics, proteomics, and methyl profiling. We highlight computational methods to help identify regionally distant patients with similar phenotypes or similar genetic mutations. Finally, we describe approaches to automate and accelerate genomic analysis. The strategies discussed here are intended to serve as a guide for clinicians and researchers in the next steps when encountering patients with non-diagnostic exomes.
1
A substantial proportion of rare-disease patients remains undiagnosed after exome sequencing, requiring diagnostic strategies beyond exome analysis.
2
Automated and accelerated genomic-analysis approaches are needed to improve the efficiency of evaluating patients with non-diagnostic exomes.
3
Computational methods can identify geographically distant patients with similar phenotypes or genetic mutations, supporting rare-disease diagnosis.
4
Gene panels, microarrays, and exome sequencing identify molecular diagnoses in approximately 25–35% of previously undiagnosed patients, often yielding actionable findings.
5
Whole-genome sequencing and complementary long-read, pan-genome, transcriptomic, metabolomic, proteomic, and methylation technologies may reveal diagnoses missed by exome sequencing.

rare and undiagnosed disease patients with non-diagnostic exomes

post-exome diagnostic strategies and technologies for identifying the molecular causes of disease

Publication Details
Publication Date
2022-02-27
Journal
Publisher
ISSN
Cited by
393
Access Type
Author Information
Authors
Joshua W. Knowles
Euan Angus Ashley
Shruti Marwaha
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%